ADPRS, His-Tag Recombinant

Catalog #
101852
$350 *
Size: 25 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human ADPRS (ADP-ribosyl-acceptor hydrolase 3, or ARH3), full length encompassing amino acids 2-363(end). This construct contains an N-terminal His-tag (6xHis). This protein was affinity purified.

Synonyms
ADP-ribosylhydrolase ARH3, ADP-ribose glycohydrolase ARH3, ADP-ribosylhydrolase 3, O-acetyl-ADP-ribose deacetylase ARH3, Poly(ADP-ribose) glycohydrolase ARH3, ADPRHL2, ARH3
Product Info
Storage and Usage
Citations
Species
Human
Construct
ADPRS (His-2-363(end))
Host Species/Expression System
E. coli
Purity

≥90%

Format

Aqueous buffer solution.

Formulation

40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 20% glycerol, and 3 mM DTT

MW
40 kDa
Amino Acids
2-363(end)
Genbank #
NM_017825.3
UniProt #
Q9NX46
Tag(s)
N-terminal His-Tag
Background

ADPRS, also known as ADP-ribosyl-acceptor hydrolase 3 or ARH3, is part of the DNA damage response machinery, and removes ADP-ribose from serine residues in a Mg2+-dependent manner. It acts sequentially to PARG (poly(ADP-ribose) glycohydrolase) and it has a protective role by decreasing the levels of PAR in the cell, which stops mitochondria from releasing PAR-driven AIF (apoptosis inducing factor). Mutations that result in loss of function of this protein lead to CONDSIAS (stress-induced childhood-onset neurodegeneration with variable ataxia and seizures), a disease with multiple clinical expressions. The development and use of ADPRS inhibitors allows us a better understanding of the DNA damage response pathway and opens new avenues for cancer treatment.